Vis enkel innførsel

dc.contributor.authorMadsen, Anders
dc.contributor.authorBrokstad, Rebecca Jane Cox
dc.date.accessioned2021-07-07T07:39:42Z
dc.date.available2021-07-07T07:39:42Z
dc.date.created2020-07-29T13:26:32Z
dc.date.issued2020-07-06
dc.PublishedVaccines. 2020, 8 (3), 1-12.
dc.identifier.issn2076-393X
dc.identifier.urihttps://hdl.handle.net/11250/2763650
dc.description.abstractCurrent influenza vaccines offer suboptimal protection and depend on annual reformulation and yearly administration. Vaccine technology has rapidly advanced during the last decade, facilitating development of next-generation influenza vaccines that can target a broader range of influenza viruses. The development and licensure of a universal influenza vaccine could provide a game changing option for the control of influenza by protecting against all influenza A and B viruses. Here we review important findings and considerations regarding the development of universal influenza vaccines and what we can learn from this moving forward with a SARS-CoV-2 vaccine design.en_US
dc.language.isoengen_US
dc.publisherMDPIen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleProspects and challenges in the development of universal influenza vaccinesen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright the authorsen_US
dc.source.articlenumber361en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doi10.3390/vaccines8030361
dc.identifier.cristin1820905
dc.source.journalVaccinesen_US
dc.source.408
dc.source.143
dc.relation.projectNorges forskningsråd: 271160en_US
dc.relation.projectNorges forskningsråd: 284930en_US
dc.relation.projectNorges forskningsråd: 811752en_US
dc.relation.projectNorges forskningsråd: 815818en_US
dc.identifier.citationVaccines. 2020, 8, 361.en_US
dc.source.volume8en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal